Newsroom

Press Releases

Apollo Hospital in New Delhi Initiates First Non-Invasive ZAP-X Brain Tumor Treatment in South Asia

March 8, 2024

ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State

March 5, 2024

ZAP-X Marks a Milestone with First Patient Treatment in Korea

February 8, 2024

ZAP-X Gyroscopic Radiosurgery Platform Set to Revolutionize Neurosurgery at N. Copernicus Hospital in Gdansk

February 6, 2024

Westchester Medical Center to Debut ZAP-X Gyroscopic Radiosurgery System, Marking a Milestone for New York

January 16, 2024

ZAP Surgical Announces Multi-System Order, Broadening Its Brain Tumor Treatment Footprint in the United Kingdom, Germany, and Spain

December 21, 2023

ZAP Surgical Announces 3rd Installation of its Novel Non-Invasive Brain Tumor Treatment Platform in Germany

December 14, 2023

Kamiyacho Neurosurgical Clinic in Japan Celebrates First Brain Tumor Patient Treated with the New ZAP-X® Gyroscopic Radiosurgery® Platform

October 24, 2023

ZAP Surgical Deals Two More Blows to Elekta in IP Suit, Removing Barriers to Mass Adoption of the ZAP-X Radiosurgery Platform

September 27, 2023

ZAP Surgical Announces Upcoming Installation of Next-Generation ZAP-X Gyroscopic Radiosurgery in Ankara, Turkey

September 26, 2023

Brain Tumor Surgery Without the Knife Proving to be Just What the Doctor Ordered

August 9, 2023

ZAP Surgical Receives National Medical Products Administration (NMPA) Approval in China

June 29, 2023

ZAP Surgical Announces Upcoming Installation of Novel Non-Invasive Brain Tumor Treatment System in South Korea

June 13, 2023

First ZAP-X Gyroscopic Radiosurgery Treatments Commence in France

May 22, 2023

ZAP Surgical Announces 1,000th Patient Treated with Its Groundbreaking ZAP-X Gyroscopic Radiosurgery Platform

April 19, 2023

ZAP Surgical Receives Regulatory Approval in India

April 7, 2023

First ZAP-X Gyroscopic Radiosurgery Platform Installation in Poland

November 12, 2022

The Institut du Cancer Courlancy to Acquire ZAP-X Radiosurgery Platform

September 27, 2022

Neurosurgery One in Littleton, Colorado Treats First Patient with ZAP-X

August 29, 2022

Chairman of Foxconn Technology Joins Board of Directors

June 30, 2022

ZAP CEO, Dr. John R. Adler, Receives Prestigious Janeway Medal

May 26, 2022

Baptist Health South Florida to Acquire ZAP-X

April 27, 2022

Renown French Oncology Research Group Selects ZAP Surgical Technology

March 12, 2022

Commissioner of Patents Rejects Elekta’s Request to Reverse 2021 Decision Invalidating Its Patent Claims

March 9, 2022

Apollo Hospital in New Delhi Initiates First Non-Invasive ZAP-X Brain Tumor Treatment in South Asia

March 8, 2024

ZAP Surgical Announces Additional Installation of Its State-of-the-Art ZAP-X Brain Tumor Treatment System in New York State

March 5, 2024

ZAP-X Marks a Milestone with First Patient Treatment in Korea

February 8, 2024

ZAP-X Gyroscopic Radiosurgery Platform Set to Revolutionize Neurosurgery at N. Copernicus Hospital in Gdansk

February 6, 2024

Westchester Medical Center to Debut ZAP-X Gyroscopic Radiosurgery System, Marking a Milestone for New York

January 16, 2024

ZAP Surgical Announces Multi-System Order, Broadening Its Brain Tumor Treatment Footprint in the United Kingdom, Germany, and Spain

December 21, 2023

ZAP Surgical Announces 3rd Installation of its Novel Non-Invasive Brain Tumor Treatment Platform in Germany

December 14, 2023

Kamiyacho Neurosurgical Clinic in Japan Celebrates First Brain Tumor Patient Treated with the New ZAP-X® Gyroscopic Radiosurgery® Platform

October 24, 2023

ZAP Surgical Deals Two More Blows to Elekta in IP Suit, Removing Barriers to Mass Adoption of the ZAP-X Radiosurgery Platform

September 27, 2023

ZAP Surgical Announces Upcoming Installation of Next-Generation ZAP-X Gyroscopic Radiosurgery in Ankara, Turkey

September 26, 2023

Brain Tumor Surgery Without the Knife Proving to be Just What the Doctor Ordered

August 9, 2023

ZAP Surgical Receives National Medical Products Administration (NMPA) Approval in China

June 29, 2023

ZAP Surgical Announces Upcoming Installation of Novel Non-Invasive Brain Tumor Treatment System in South Korea

June 13, 2023

First ZAP-X Gyroscopic Radiosurgery Treatments Commence in France

May 22, 2023

ZAP Surgical Announces 1,000th Patient Treated with Its Groundbreaking ZAP-X Gyroscopic Radiosurgery Platform

April 19, 2023

ZAP Surgical Receives Regulatory Approval in India

April 7, 2023

First ZAP-X Gyroscopic Radiosurgery Platform Installation in Poland

November 12, 2022

The Institut du Cancer Courlancy to Acquire ZAP-X Radiosurgery Platform

September 27, 2022

Neurosurgery One in Littleton, Colorado Treats First Patient with ZAP-X

August 29, 2022

Chairman of Foxconn Technology Joins Board of Directors

June 30, 2022

ZAP CEO, Dr. John R. Adler, Receives Prestigious Janeway Medal

May 26, 2022

Baptist Health South Florida to Acquire ZAP-X

April 27, 2022

Renown French Oncology Research Group Selects ZAP Surgical Technology

March 12, 2022

Commissioner of Patents Rejects Elekta’s Request to Reverse 2021 Decision Invalidating Its Patent Claims

March 9, 2022

Media Resources

Download photography, logos and resources for the media.

Media Contact

For additional questions contact:

Mark Arnold
Senior VP, Marketing

About ZAP

Our vision for the future of brain cancer and the team fighting to make it happen.